Geode Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.4M | Buy |
1,029,616
+65,951
| +7% | +$3.36M | ﹤0.01% | 1394 |
|
|
2025
Q1 | $43.4M | Buy |
963,665
+20,321
| +2% | +$916K | ﹤0.01% | 1457 |
|
|
2024
Q4 | $39M | Buy |
943,344
+7,147
| +0.8% | +$296K | ﹤0.01% | 1591 |
|
|
2024
Q3 | $36.5M | Buy |
936,197
+29,017
| +3% | +$1.13M | ﹤0.01% | 1633 |
|
|
2024
Q2 | $31M | Buy |
907,180
+210,041
| +30% | +$7.18M | ﹤0.01% | 1681 |
|
|
2024
Q1 | $17.5M | Buy |
697,139
+15,959
| +2% | +$401K | ﹤0.01% | 2004 |
|
|
2023
Q4 | $20.1M | Buy |
681,180
+106,100
| +18% | +$3.13M | ﹤0.01% | 1922 |
|
|
2023
Q3 | $18.2M | Buy |
575,080
+49,518
| +9% | +$1.56M | ﹤0.01% | 1879 |
|
|
2023
Q2 | $13.6M | Buy |
525,562
+107,348
| +26% | +$2.78M | ﹤0.01% | 2103 |
|
|
2023
Q1 | $10M | Buy |
418,214
+18,532
| +5% | +$445K | ﹤0.01% | 2248 |
|
|
2022
Q4 | $7.79M | Buy |
399,682
+20,180
| +5% | +$393K | ﹤0.01% | 2422 |
|
|
2022
Q3 | $7.97M | Buy |
379,502
+98,642
| +35% | +$2.07M | ﹤0.01% | 2397 |
|
|
2022
Q2 | $5.47M | Buy |
280,860
+84,422
| +43% | +$1.64M | ﹤0.01% | 2656 |
|
|
2022
Q1 | $4.33M | Buy |
196,438
+23,545
| +14% | +$518K | ﹤0.01% | 2880 |
|
|
2021
Q4 | $2.76M | Sell |
172,893
-3,780
| -2% | -$60.3K | ﹤0.01% | 3211 |
|
|
2021
Q3 | $3.52M | Buy |
176,673
+2,402
| +1% | +$47.8K | ﹤0.01% | 3116 |
|
|
2021
Q2 | $3.01M | Buy |
174,271
+1,841
| +1% | +$31.8K | ﹤0.01% | 3142 |
|
|
2021
Q1 | $3.42M | Buy |
172,430
+60,218
| +54% | +$1.19M | ﹤0.01% | 2966 |
|
|
2020
Q4 | $1.96M | Buy |
112,212
+2,285
| +2% | +$39.9K | ﹤0.01% | 3100 |
|
|
2020
Q3 | $2.12M | Buy |
109,927
+5,387
| +5% | +$104K | ﹤0.01% | 2851 |
|
|
2020
Q2 | $2.03M | Buy |
104,540
+11,182
| +12% | +$218K | ﹤0.01% | 2826 |
|
|
2020
Q1 | $1.31M | Buy |
93,358
+34,790
| +59% | +$487K | ﹤0.01% | 2898 |
|
|
2019
Q4 | $1.44M | Buy |
58,568
+37,510
| +178% | +$920K | ﹤0.01% | 3142 |
|
|
2019
Q3 | $211K | Buy |
+21,058
| New | +$211K | ﹤0.01% | 3745 |
|